These Analysts Raise Their Forecasts On VeriSign After Strong Q1 Results VeriSign, Inc (
NASDAQ:VRSN ) reported upbeat Q1 earnings, beating analyst estimates. Sales also exceeded expectations. FY2026 sales guidance raised.
Nasdaq 100 Marks Fresh Records, Intel Jumps 23% On AI Chip Mania: Stock Market Today Nasdaq 100 hit a fresh record as Intel surged 23% on a blowout quarter, while Charter Communications cratered and WTI sank 2% on Iran talks.
Amazon's Unconventional Path to Profitability: What It Meant for Shareholders The company did not focus on GAAP profitability to the delight of long-term shareholders.
Union Pacific Analysts Increase Their Forecasts Following Upbeat Q1 Earnings Union Pacific reported better-than-expected Q1 earnings, with a 3% increase in operating revenue and reaffirmed its 2026 outlook.
Oilfield Giant Baker Hughes Defies Middle East Chaos With Stellar Earnings Beat Baker Hughes (BKR) surges 4% after beating Q1 profit forecasts. Read highlights on revenue, IET orders, and portfolio updates.
3 Ways Your Side Hustle Could Affect Your Social Security Benefits in 2026 Just because you're receiving checks now doesn't mean your take-home benefit is set in stone.
American Express Reports Q1 Beat, Stock Tanks On 2026 Outlook American Express shares came under pressure after Q1 results. Markets were disappointed by the company maintaining 2026 outlook.
These Analysts Revise Their Forecasts On Boyd Gaming After Q1 Results Boyd Gaming (BYD) reported worse-than-expected Q1 results and announced a $500 million buyback plan. Analysts lowered price targets.
The Smartest Dividend ETF to Buy With $2,000 in April 2026 If your investment philosophy rests on generating steady and dependable income, you've come to the right place.
These Analysts Increase Their Forecasts On Churchill Downs After Upbeat Q1 Results Churchill Downs Inc (
NASDAQ:CHDN ) reported better-than-expected earnings and saw a 3.2% increase in stock price. Analysts have raised price targets.
Middle East Issues Hit SLB Operations, Profit SLB reports lower earnings despite revenue beat as Middle East disruptions impact operations and margins in Q1 2026.
Stock Market Today, April 24:Tech Strength Drives Midday Markets Chip-fueled gains drove the Nasdaq ahead even as cyclicals and financials dragged on the Dow, today, April 24, 2026.
Capricorn Fund Managers Dumps $18.4 Million Worth of Waystar Stock in Q1 Waystar delivers cloud-based payment solutions for healthcare providers, supporting over $1 billion in annual revenue with a SaaS model.
Auddia Shares Sink After $12 Million Offering As Volatility Spikes Auddia stock plunges over 60% after pricing a $12M public offering, reversing gains and trading near 52-week lows.
FirstCash Analysts Boost Their Forecasts Following Better-Than-Expected Q1 Earnings FirstCash Holdings Inc (
NASDAQ:FCFS ) reported impressive Q1 earnings, beating analyst estimates. Stock rose 4.1% to $220.98. Analysts raised price targets.
Procter & Gamble Sees $150 Million Hit From From Middle East Disruptions, Maintains Outlook Procter & Gamble beats Q3 earnings and revenue estimates. Check out the latest on P&G's fiscal 2026 outlook and stock movement.
DOJ Drops Powell Probe: Betting Markets Say Warsh Is Fed Chair By May 15 Prediction market odds on Kevin Warsh being confirmed Fed Chair by May 15 surged to 84% after DOJ dropped its criminal probe of Jerome Powell.
Senators Demand Probe Of FAA Administrator Over Delayed Republic Airways Stock Sale Senate Democrats call for ethics probe into FAA's Bryan Bedford as RJET stock trends lower amid rising fuel costs.
Intel, Micron, AMD: 5 Dot-Com-Era Red Flags Just Reappeared In The Market Five semiconductor signals just fired together for the first time since the dot-com bubble. Every stock on the list is already above consensus targets.
Why Pineapple Financial Stock Is Surging Today Pineapple Financial Inc (
NASDAQ:PAPL ) shares are surging Friday on an expanded buyback plan, fueling momentum in the thinly traded name.
Edwards Lifesciences Stock Surges On Heart Valve Devices Growth Edwards Lifesciences shares rise after Q1 earnings beat, with strong valve therapy growth and updated 2026 outlook amid mixed analyst views.
